When ChatGPT arrived in late 2022, it kicked off an AI boom that hasn't stopped since and showed how powerful ...
Aviceda Therapeutics ("the Company" or "Aviceda"), a clinical-stage biotechnology company developing innovative therapies for retinal diseases, today announced topline results from its SIGLEC Phase 2b ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback